Paul V Maier
Director at Eton Pharmaceuticals, Inc. (ETON)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 31SEC | ETONEton Pharmaceuticals, Inc. | Sell | 36,38773,358 held (−33%) | $58.64 | $2.1M | -5.8% |
| Aug 31SEC | ETONEton Pharmaceuticals, Inc. | Sell | 13,48559,873 held (−18%) | $60.21 | $812K | -8.3% |
| Aug 31SEC | ETONEton Pharmaceuticals, Inc. | Sell | 12859,745 held (−0%) | $61.77 | $8K | -10.6% |
| Aug 28SEC | ETONEton Pharmaceuticals, Inc. | Sell | 36,38773,358 held (−33%) | $58.64 | $2.1M | -5.8% |
| Aug 28SEC | ETONEton Pharmaceuticals, Inc. | Sell | 13,48559,873 held (−18%) | $60.21 | $812K | -8.3% |
| Aug 28SEC | ETONEton Pharmaceuticals, Inc. | Sell | 12859,745 held (−0%) | $61.77 | $8K | -10.6% |
- Sell
Director Paul V Maier sold $2.1M of ETON at $58.64 — cuts the stake by 33%.
- Sell
Director Paul V Maier sold $2.1M of ETON at $58.64 — cuts the stake by 33%.